FAM200A抗体;FAM200A Antibody—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P09260(TDGF1 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

The FAM200A antibody is designed to target the FAM200A protein, encoded by the FAM200A gene, which belongs to the family with sequence similarity (FAM) group. This protein is evolutionarily conserved and widely expressed across human tissues, though its precise biological functions remain under investigation. Preliminary studies suggest potential roles in cellular processes such as DNA repair, cell cycle regulation, or epigenetic modulation. FAM200A has garnered interest due to its possible involvement in pathological conditions, including cancer. Some research indicates differential expression patterns in tumors, linking it to tumor suppression or oncogenic pathways, though findings are context-dependent and require further validation.

FAM200A antibodies, typically developed as polyclonal or monoclonal variants, are essential tools for detecting and quantifying FAM200A in experimental settings like Western blotting, immunohistochemistry, and immunofluorescence. These antibodies enable researchers to map protein localization, assess expression levels in diseased versus healthy tissues, and explore interactions with other biomolecules. Current studies focus on clarifying FAM200A’s mechanistic contributions to cellular homeostasis and disease progression, particularly in oncology and developmental biology. As research advances, FAM200A antibodies may support diagnostic or therapeutic innovations, though their clinical utility remains speculative. Validation of specificity and cross-reactivity is critical due to homology within the FAM protein family.